DK124989B - Fremgangsmåde til fremstilling af en stabil vandig suspension af calcium-(-)-(cis-1,2-epoxypropyl)-phosphonat. - Google Patents

Fremgangsmåde til fremstilling af en stabil vandig suspension af calcium-(-)-(cis-1,2-epoxypropyl)-phosphonat.

Info

Publication number
DK124989B
DK124989B DK280570AA DK280570A DK124989B DK 124989 B DK124989 B DK 124989B DK 280570A A DK280570A A DK 280570AA DK 280570 A DK280570 A DK 280570A DK 124989 B DK124989 B DK 124989B
Authority
DK
Denmark
Prior art keywords
epoxypropyl
phosphonate
cis
calcium
preparation
Prior art date
Application number
DK280570AA
Other languages
English (en)
Inventor
Neill J O
D Allen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK124989B publication Critical patent/DK124989B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK280570AA 1969-06-02 1970-06-01 Fremgangsmåde til fremstilling af en stabil vandig suspension af calcium-(-)-(cis-1,2-epoxypropyl)-phosphonat. DK124989B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82978569A 1969-06-02 1969-06-02

Publications (1)

Publication Number Publication Date
DK124989B true DK124989B (da) 1972-12-18

Family

ID=25255551

Family Applications (1)

Application Number Title Priority Date Filing Date
DK280570AA DK124989B (da) 1969-06-02 1970-06-01 Fremgangsmåde til fremstilling af en stabil vandig suspension af calcium-(-)-(cis-1,2-epoxypropyl)-phosphonat.

Country Status (13)

Country Link
US (1) US3678163A (da)
BE (1) BE750811A (da)
CA (1) CA931077A (da)
DE (1) DE2026740A1 (da)
DK (1) DK124989B (da)
FI (1) FI47961C (da)
FR (1) FR2051568B1 (da)
GB (1) GB1263654A (da)
IE (1) IE34331B1 (da)
IL (1) IL34552A (da)
NL (1) NL7006857A (da)
SE (1) SE370865B (da)
ZA (1) ZA703677B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029782A (en) * 1975-04-28 1977-06-14 Eli Lilly And Company Cefazolin suspension for parenteral administration
DE2522081A1 (de) * 1975-05-17 1976-11-25 Boehringer Mannheim Gmbh Antibiotisch wirksames praeparat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3351527A (en) * 1964-10-01 1967-11-07 American Home Prod Stabilized benzathine penicillin compositions

Also Published As

Publication number Publication date
FR2051568B1 (da) 1974-04-12
IL34552A (en) 1973-02-28
FI47961C (fi) 1974-05-10
US3678163A (en) 1972-07-18
IL34552A0 (en) 1970-07-19
BE750811A (fr) 1970-11-23
DE2026740A1 (de) 1970-12-10
GB1263654A (en) 1972-02-16
FR2051568A1 (da) 1971-04-09
SE370865B (da) 1974-11-04
FI47961B (da) 1974-01-31
ZA703677B (en) 1972-01-26
IE34331B1 (en) 1975-04-16
CA931077A (en) 1973-07-31
NL7006857A (da) 1970-12-04
IE34331L (en) 1970-12-02

Similar Documents

Publication Publication Date Title
DK138951B (da) Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin.
DK134559B (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycinforbindelser.
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
FI50979C (fi) Menetelmä mikrobeja tuhoavan 2-amino-4-hydroksi-6-hydroksimetyyli-7,7- dimetyyli-7,8-dihydropteridiinin tai sen tautomeerisen muodon valmista miseksi.
FI45039C (fi) Analogiamenetelmä uuden amiinin valmistamiseksi.
DK140694B (da) Fremgangsmåde til fremstilling af alkyl-trans-chrysanthemater eller den tilsvarende frie syre.
DK138898B (da) Fremgangsmåde til fremstilling af N-phosphonomethylglycin.
DK124989B (da) Fremgangsmåde til fremstilling af en stabil vandig suspension af calcium-(-)-(cis-1,2-epoxypropyl)-phosphonat.
DK124336B (da) Fremgangsmåde til fremstilling af de antibiotiske stoffer (-)(cis-1,2-epoxypropyl)-phosphonsyre eller et salt heraf.
DK130745B (da) Fremgangsmåde til fremstilling af transparente copolyamider.
FI46262C (fi) Mikrobiologinen menetelmä (-)(cis-1,2-epoksipropyyli)fosfonihapon valm istamiseksi.
DK132329B (da) Fremgangsmåde til fremstilling af cardenolid-3,alfa-/2'-desoxy-glycosider/.
DK136069B (da) Fremgangsmåde til fremstilling af quinolinderivater, antipoder eller racemater eller syreadditionssalte deraf.
DK132305B (da) Fremgangsmåde til fremstilling af en stabil, klar vitaminholdig jernopløsning.
DK140897B (da) Fremgangsmåde til fremstilling af en triester af N-phosphonomethylglycin.
DK137928B (da) Fremgangsmåde til fremstilling af 5alfa-hydroxygona-9,11-diener.
DK131381B (da) Fremgangsmåde til fremstilling af en metabolit, sesquicillin.
FI45985C (fi) Menetelmä (-)(cis-1,2-epoksipropyyli)-fosfonihapon valmistamiseksi.
FI45984C (fi) Menetelmä (-)(cis-1,2-epoksipropyyli)-fosfonihapon valmistamiseksi.
DK131037B (da) Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-østren-17beta-oler.
DK105824C (da) Fremgangsmåde til fremstilling af en vandopløselig tilberedningsform af 3,5-dinitro-o-toluamid.
SE394815B (sv) Sett att framstella vissa angivna (3-benso-1,2,4-triazinyl-dioxid-1,4)-karbamider
DK132279B (da) Fremgangsmåde til fremstilling af (-)(cis-1,2-epoxypropyl)-phosphonsyre og salte deraf.
DK135133B (da) Fremgangsmåde til fremstilling af 21-fluor-16alfa,17alfa-alkylidendioxy-20-oxo-steroider.
DK137190B (da) Fremgangsmåde til fremstilling af 6beta-amino-2,2-dimetylpenam-3alfa-karboxylsyre.